X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://health.economictimes.indiatimes.com/news/pharma/usfda-issues-complete-response-letter-for-proposed-biosimilar-insulin-aspart-biocon/104253768
https://www.ema.europa.eu/en/documents/product-information/truvelog-mix-30-epar-product-information_en.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208751
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208751
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208751
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-cut-price-insulin-by-up-75-wsj-2023-03-14/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203313
https://www.ema.europa.eu/en/documents/overview/truvelog-mix-30-epar-summary-public_en.pdf
https://www.outlookindia.com/website/story/business-news-usfda-rejects-biocon-viatris-application-for-insulin-aspart/408790
https://www.globenewswire.com/news-release/2021/11/26/2341313/0/en/Novo-Nordisk-announces-impact-from-Volume-Based-Procurement-for-insulin-in-China.html
https://www.ema.europa.eu/en/documents/overview/insulin-aspart-sanofi-epar-medicine-overview_en.pdf
https://www.fiercebiotech.com/research/ultrafast-insulin-by-stanford-team-cuts-peak-time-to-minutes-pigs
https://www.prnewswire.com/news-releases/fda-approves-fiasp-for-treatment-of-children-with-diabetes-300981601.html
http://www.pharmatimes.com/news/az_bags_two_extensions_in_latest_chmp_decisions_1292946
http://www.pmlive.com/pharma_news/novo_nordisk_preps_for_speedy_oral_glp-1_drug_filing_1277020
https://www.drugdeliverybusiness.com/europe-oks-novo-nordisks-fiasp-for-insulets-omnipod/?spMailingID=14364834&spUserID=MjYwMjgyNDM1ODMxS0&spJobID=1500229714&spReportId=MTUwMDIyOTcxNAS2
https://www.fiercepharma.com/pharma/revlimid-and-pomalyst-price-increases-could-celgene-be-next-trump-s-to-call-list
https://www.bloomberg.com/news/articles/2018-07-10/drugmakers-cancel-price-hikes-as-california-law-takes-effect
https://platform.mi.spglobal.com/web/client?auth=inherit#news/article?id=43852931&cdid=A-43852931-11822
http://www.fiercepharma.com/special-report/top-10-diabetes-drugs-by-2016-sales
https://www.pharmacompass.com/pdf/news/novo-nordisk-gets-eu-nod-for-fiasp-insulin-aspart-1486203730.pdf
http://www.fiercepharma.com/pharma/novo-ceo-cites-volatile-environment-u-s-politics-cut-to-2017-growth-prospects
https://globenewswire.com/news-release/2017/01/10/904755/0/en/Fiasp-fast-acting-insulin-aspart-approved-in-Europe.html
http://www.fiercepharma.com/pharma/analysts-to-wall-street-drug-pricing-brouhaha-far-from-over
http://www.pharmatimes.com/news/nine_therapies_put_forward_for_eu_approval_1176576
https://www.pharmacompass.com/pdf/news/novo-receives-positive-opinion-from-european-drug-authorities-fiasp-1478950185.pdf
http://www.marketwatch.com/story/eli-lillys-revenue-boosted-by-higher-drug-prices-for-diabetics-2016-01-28?
https://www.pharmacompass.com/pdf/news/novo-nordisks-generic-ryzodeg-approved-in-us-for-diabetes-mellitus-1443609093.pdf
http://www.fiercedrugdelivery.com/story/fda-requires-new-labeling-insulin-pens-ward-spread-infections/2015-03-03
http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/Press%20Room/Top_line_data/2014/Top_20_Global_Products_2014.pdf
Market Place
Share 
